CIK 0001645469 · Non-accelerated filer<br>Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320463781
- Phone
- 8473880349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,335,315
- in 9 filings, $5.3M under 10b5-1 plans
Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-26 | RIOUX PATRICE Acting Chief Medical Officer | Option exercise 10b5-1 | +1,380 | $0.01 | $7 | 5,066 |
| 2026-08-26 | RIOUX PATRICE Acting Chief Medical Officer | Sale 10b5-1 | −1 | $111.26 | $111 | 5,065 |
| 2026-08-26 | RIOUX PATRICE Acting Chief Medical Officer | Option exercise · Stock Option 10b5-1 | +1,380 | 0 | ||
| 2026-01-01 | RIOUX PATRICE Acting Chief Medical Officer | Grant or award · Stock Option | +2,000 | 2,000 | ||
| 2025-01-01 | RIOUX PATRICE Acting Chief Medical Officer | Grant or award · Stock Options | +2,000 | 2,000 | ||
| 2024-01-01 | RIOUX PATRICE Acting Chief Medical Officer | Grant or award · Stock Options | +10,000 | 10,000 |
Page 1 of 1 · 6 trades